Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stockholm - Delayed Quote SEK

Swedencare AB (publ) (SECARE.ST)

Compare
46.08
+0.40
+(0.88%)
At close: February 21 at 5:29:42 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,539,900
2,539,900
2,338,300
1,843,300
770,441
Cost of Revenue
1,080,400
1,080,400
1,047,500
813,900
384,569
Gross Profit
1,459,500
1,459,500
1,290,800
1,029,400
385,872
Operating Expense
1,234,500
1,234,500
1,117,600
909,300
321,198
Operating Income
225,000
225,000
173,200
120,100
64,674
Net Non Operating Interest Income Expense
-73,500
-73,500
-92,300
-40,300
-7,654
Pretax Income
150,500
150,500
81,100
80,100
56,901
Tax Provision
51,600
51,600
22,500
-14,400
2,279
Net Income Common Stockholders
98,900
98,900
58,600
94,500
54,622
Diluted NI Available to Com Stockholders
98,900
98,900
58,600
94,500
54,622
Basic EPS
0.62
--
0.37
0.61
0.49
Diluted EPS
0.62
--
0.37
0.61
0.49
Basic Average Shares
158,786.64
--
158,731.90
155,346.21
111,951.30
Diluted Average Shares
158,786.64
--
158,731.90
155,346.21
111,951.30
Total Operating Income as Reported
225,000
225,000
173,200
120,000
64,555
Total Expenses
2,314,900
2,314,900
2,165,100
1,723,200
705,767
Net Income from Continuing & Discontinued Operation
98,900
98,900
58,600
94,500
54,622
Normalized Income
98,965.71
98,965.71
58,600
96,564.40
54,736.23
Interest Income
8,700
8,700
1,800
300
1,355
Interest Expense
82,200
82,200
94,100
40,600
9,009
Net Interest Income
-73,500
-73,500
-92,300
-40,300
-7,654
EBIT
232,700
232,700
175,200
120,700
65,910
EBITDA
548,600
548,600
485,000
390,000
138,852
Reconciled Cost of Revenue
1,080,400
1,080,400
1,047,500
813,900
384,569
Reconciled Depreciation
315,900
315,900
309,800
269,300
72,942
Net Income from Continuing Operation Net Minority Interest
98,900
98,900
58,600
94,500
54,622
Total Unusual Items Excluding Goodwill
-100
-100
100
-2,600
-119
Total Unusual Items
-100
-100
100
-2,600
-119
Normalized EBITDA
548,700
548,700
485,000
392,600
138,971
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-34.29
-34.29
--
-535.60
-4.77
12/31/2021 - 6/14/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CINPHA.ST Cinclus Pharma Holding AB (publ)
16.00
+1.89%
 
MRK.BE Merck KGaA
135.95
+1.15%
 
SOBI.ST Swedish Orphan Biovitrum AB (publ)
312.40
-1.08%
 
MOB.ST Moberg Pharma AB (publ)
9.06
-0.06%
 
TKNO Alpha Teknova, Inc.
7.45
-6.76%
 
LNTH Lantheus Holdings, Inc.
78.23
-3.23%
 
UPC Universe Pharmaceuticals INC
0.2014
+41.33%
 
ACB Aurora Cannabis Inc.
5.89
+0.51%